Generics and biosimilars: innovation not imitation - PharmaTimes…
The generic medicines industry is moving beyond making copies to developing patent-expired products, with new formulations, dosages and delivery methods - Magazine Article - PharmaTimes
by Peter Kelly, managing director at Accord UK and vice-chair of the British Generics Manufacturing Association
https://www.pharmatimes.com/magazine/2022/januaryfebruary_2022/generics_and_biosimilars_innovation_not_imitation